Related Experiment Videos
Weight loss in Alzheimer's disease
1Department of Neurology, Massachusetts General Hospital, Boston, 02114.
Journal of Geriatric Psychiatry and Neurology
|January 1, 1993
Summary
Weight loss in Alzheimer's disease (AD) patients is a consequence of the condition, not a direct result of brain lesions. This study found weight loss correlated with reduced self-feeding independence in AD outpatients.
Area of Science:
- Neurology
- Gerontology
- Clinical Nutrition
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Weight loss is frequently observed in AD patients, but its cause remains debated.
- Distinguishing core symptoms from secondary manifestations is crucial for effective patient management.
Purpose of the Study:
- To investigate whether weight loss is a primary symptom or a secondary consequence of Alzheimer's disease.
- To analyze the relationship between weight change and various clinical factors in AD outpatients.
Main Methods:
- Prospective observational study involving 81 outpatients diagnosed with Alzheimer's disease.
- Weight changes were monitored over a mean observation period of 2.9 years.
- Statistical analyses were performed to correlate weight change with dementia duration, severity, self-feeding ability, psychiatric symptoms, and medications.
Main Results:
- A statistically significant mean absolute weight loss of 1.9 kg (approximately 3% of initial body weight) was observed over the study period.
- Mean annual weight loss was 0.7 kg.
- Weight change was strongly correlated with decreased independence in self-feeding (P < .0001).
- No significant relationship was found between weight change and dementia duration, severity, psychiatric symptoms, or medication use.
Conclusions:
- Weight loss in Alzheimer's disease appears to be a consequence of the disease process, particularly related to functional decline in self-feeding.
- The findings suggest that weight loss is a secondary manifestation rather than a core symptom directly linked to specific brain lesions in AD.